Tiffany, Kors to Re...
Health Care: Drugs
Eli Lilly and Company (LLY: NYSE)
$54.14 -0.60 | -1.10%
05/24/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 54.74 |
| 52 Week High | 58.41 |
| 52 Week Low | 39.93 |
| Avg. Daily Vol. (Mil) | 5.07 |
| Beta (3 year) | 0.42 |
| Share Related Items | |
| Mkt Cap (Mil) | 61,667.97 |
| Shares Out (Mil) | 1,126.56 |
| Float (Mil) | 992.73 |
| Dividend Information | |
| Yield % | 3.60 |
| Annual Dividend | 1.96 |
| Payout Ratio | 47.00 |
| Financial Strength | |
| Quick Ratio | 1.20 |
| Current Ratio | 1.60 |
| LT Debt/ Equity | 0.30 |
| Total Debt / Equity | 0.37 |
| Valuation Ratios | |
| Price Earnings | 13.10 |
| Price/Sales | 2.73 |
| Price/Book | 4.13 |
| Price/Cash Flow | 8.70 |
| Per Share Data | |
| Earnings | 4.17 |
| Sales | 20.06 |
| Book Value | 13.27 |
| Cash Flow | 6.30 |
| Business Summary | |
|---|---|
| Eli Lilly and Company is a drug manufacturing company. It discovers, develops, manufactures, and sells products in two business segments: human pharmaceutical products and animal health products. | |
| General Information | |
| Lilly Corporate Center
Drop Code 1112 Indianapolis, IN 46285 |
|
| www.lilly.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 38350 | |
| CEO: Mr. Derica W. Rice | |
| Short Interest | |
| Current Month (Mil) | 14.49 |
| Previous Month (Mil) | 14.97 |
| Short Interest Ratio (Days) | 3.30 |
| Management Effectiveness | |
| Return on Equity | 37.70 |
| Return on Assets | 17.50 |
| Return on Investments | 29.10 |
| Profitability | |
| Gross Margin | 85.40 |
| EBIT Margin | 27.40 |
| Profit Margin | 24.90 |
Portfolios with LLY
- Portfolio NameUser Type
- ContributorHigh Volume Technicals for ...
- ProRenaissance Technologies
- Contributor8 Stocks With Big Dividends...
- ContributorStocks Rising On Unusual Vo...
- ContributorRocket Stocks for the Week ...
- UserJS&JH
- Contributor5 Bullish Stocks to Buy on ...
- UserBG Stockpickr Wish List
- UserStock Interests, Ideas & Re...
- Contributor7 High-Yield Stocks With Bu...
Latest LLY Headlines from TheStreet
- Eli Lilly And Company (LLY): Today's Featured Drugs Laggard 05.24.13 | 05:05 pm
- Eli Lilly And Company Stock Buy Recommendation Reiterated (LLY) 05.21.13 | 10:05 am
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward 05.16.13 | 01:05 pm
- Eli Lilly And Company (LLY): Today's Featured Drugs Winner 05.15.13 | 05:05 pm
- 4 Stocks Going Ex-Dividend Tomorrow: GIL, ACC, ADM, LLY 05.13.13 | 10:05 am
- Eli Lilly And Stock To Go Ex-dividend Tomorrow (LLY) 05.13.13 | 09:05 am
- 4 Stocks Pushing The Drugs Industry Downward 05.07.13 | 01:05 pm
- It's Pipeline That Matters Most 05.04.13 | 04:05 am
- Cramer's 'Mad Money' Recap: Good Earnings, Bad Market 05.01.13 | 08:05 pm
- Eli Lilly And Company (LLY): Today's Featured Health Care Laggard 04.30.13 | 05:04 pm
Press Releases for LLY
- From Research Labs To Doctors' Offices, Health Care Providers At Lilly Play Important Role In Bringing New And Innovative Medicines To Patients - PR Newswire 05.20.13 | 08:05 am
- Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint In Diffuse Large B-Cell Lymphoma - PR Newswire 05.10.13 | 08:05 am
- Retrospective Analysis Of Linagliptin Data In Sub-populations With Type 2 Diabetes Presented At AACE 22nd Annual Scientific & Clinical Congress - PR Newswire 05.06.13 | 06:05 pm
- Lilly Announces CEO Dr. John Lechleiter To Undergo Scheduled Surgery - PR Newswire 05.06.13 | 04:05 pm
- Lilly Declares Second-Quarter 2013 Dividend - PR Newswire 05.06.13 | 02:05 pm
- Boehringer Ingelheim Pharmaceuticals, Inc. And Eli Lilly And Company Launch Educational Campaign About Emerging Science In Type 2 Diabetes - PR Newswire 05.02.13 | 08:05 am
- Lilly Diabetes And Disney Publishing Worldwide Expand Collaboration - PR Newswire 04.30.13 | 08:04 am
- Lilly Celebrates National Volunteer Week With Deployment Of Global Service Teams - PR Newswire 04.26.13 | 07:04 am
- Lilly Again Named One Of DiversityInc's Top 50 Companies For Diversity - PR Newswire 04.24.13 | 11:04 am
- Lilly Acquires Novel Tau Tangle Diagnostic Program To Bolster Alzheimer's Disease Research And Development - PR Newswire 04.17.13 | 08:04 am
Partner Headlines for LLY
- J&J Q1 Earnings Beat; Pharma Strong, Devices Weak - Investor's Business Daily 04.16.13 | 04:04 pm
- Parexel Grows Earnings With Big Pharma Partnerships - Investor's Business Daily 04.04.13 | 02:04 pm
- Can New Psoriasis Drugs Scratch Investors' Itch? - Investor's Business Daily 04.04.13 | 01:04 pm
- Is the New Abbot a Winner? - Wall St. Cheat Sheet 04.02.13 | 10:04 am
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- 6 Stocks To Accumulate For A High-Yield Stable Portfolio - Seeking Alpha 02.26.13 | 09:02 am
- 2013, A Year Of Turmoil For Eli Lilly - Seeking Alpha 02.16.13 | 09:02 am
- FDA rejects Novo Nordisk insulin remedy - Financial Times 02.12.13 | 12:02 am
- Novo Nordisk Hit By Diabetes Drug Delay; Sanofi Rises - Investor's Business Daily 02.11.13 | 05:02 pm
- Novo Nordisk: reality check - Financial Times 02.11.13 | 04:02 pm
